Herantis Pharma Oyj: Manager’s Transactions - Pekka Simula
Herantis Pharma Plc
Company release 18 June 2020 at 10:00 AM Eastern European Summer Time
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Pekka Simula
Position: Chief Executive Officer
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20200617140726_5
____________________________________________
Transaction date: 2020-06-18
Venue not applicable
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: EXERCISE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 11,200 Unit price: .00005 EUR
(2): Volume: 16,000 Unit price: 2.92 EUR
Aggregated transactions
(2): Volume: 27,200 Volume weighted average price: 1.71767 EUR
____________________________________________
Further information:
Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, Finland: +358 9 25 380 225, Sweden: +358 40 5161400
Distribution:
Main media
www.herantis.com